Gelonghui, May 13丨Jinyao Pharmaceutical (600488.SH) said on the investor interactive platform that the development and production process of some of the company's products involves synthetic biology-related technology.
津药药业(600488.SH)：部分产品开发和生产过程涉及合成生物学相关技术
Tianjin Pharmaceutical (600488.SH): Some product development and production processes involve synthetic biology-related technologies
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.